FDA Brief

Warning letters Drugs

FDA warning letter to

www.usmedschoice.com

High riskIssued Oct 6, 2025Posted Oct 21, 2025Center for Drug Evaluation and Research (CDER)

FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.

What happened

FDA reviewed the website www.usmedschoice.com and found it offered opioids, benzodiazepines, and Schedule II stimulants for sale to U.S. consumers. FDA said the products were unapproved new drugs and misbranded because they lacked FDA approval and adequate directions, and some were offered without a prescription.

What FDA found

  1. The website offered drugs that are not approved by FDA for sale in the U.S.

    FD&C Act sections 301(d) and 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. The website offered prescription drugs for sale without requiring a prescription.

    FD&C Act sections 503(b)(1) and 301(k) [21 U.S.C. §§ 353(b)(1), 331(k)]
  3. The drug labeling did not include adequate directions for safe use by a layperson.

    FD&C Act section 502(f)(1) [21 U.S.C. § 352(f)(1)]
  4. The website caused misbranded drugs to be introduced into interstate commerce.

    FD&C Act section 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA requests that www.usmedschoice.com stop offering any unapproved and misbranded drugs for sale to U.S. consumers. The company must respond in writing within 15 working days with corrective steps and documentation, or explain why it believes the products comply.

Who should pay attention

  • online pharmacies and website operators selling prescription drugs
  • companies that fulfill or advertise opioids, benzodiazepines, or stimulants
  • telehealth and e-commerce platforms handling prescription drug sales

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk
  4. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk